This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Is Banco Santander (SAN) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Banco Santander (SAN) and Credicorp (BAP) have performed compared to their sector so far this year.
After Golden Cross, Credicorp (BAP)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BAP or BCH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BAP vs. BCH: Which Stock Is the Better Value Option?
Are Investors Undervaluing Credicorp (BAP) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Credicorp (BAP) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Credicorp (BAP) and JPMorgan Chase & Co. (JPM) have performed compared to their sector so far this year.
BAP vs. IBN: Which Stock Is the Better Value Option?
by Zacks Equity Research
BAP vs. IBN: Which Stock Is the Better Value Option?
Should Value Investors Buy Credicorp (BAP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Stocks With Recent Dividend Hike for a Stable Portfolio
by Nalak Das
Dividend-paying stocks should be in demand as investors try to safeguard their portfolios. Five Such stocks are: BAP, APO,NBHC, HLI and TTEK.
BAP vs. HDB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BAP vs. HDB: Which Stock Is the Better Value Option?
Are Investors Undervaluing Credicorp (BAP) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BankFinancial (BFIN) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
BankFinancial (BFIN) delivered earnings and revenue surprises of -25% and 7.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Bank of NT Butterfield & Son (NTB) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Bank of NT Butterfield & Son (NTB) delivered earnings and revenue surprises of 6.90% and 1.58%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Credicorp (BAP) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BAP or DBSDY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BAP vs. DBSDY: Which Stock Is the Better Value Option?
Should Value Investors Buy Credicorp (BAP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bank of NT Butterfield & Son (NTB) Soars 8.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bank of NT Butterfield & Son (NTB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Here's Why Credicorp (BAP) Looks Ripe for Bottom Fishing
by Zacks Equity Research
Credicorp (BAP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Are Investors Undervaluing Credicorp (BAP) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) Q4 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
Best Growth Stocks to Buy for February 2nd
by Zacks Equity Research
BAP, CNM and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 2, 2023.
Best Value Stocks to Buy for February 2nd
by Zacks Equity Research
BAP, MBIN and SNEX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 2, 2023.
Should Value Investors Buy Credicorp (BAP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for January 31st
by Zacks Equity Research
ADM, BAP and HAL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 31, 2023.
Best Value Stocks to Buy for January 31st
by Zacks Equity Research
AXS, ADM and BAP made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 31, 2023.
Credicorp (BAP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Credicorp (BAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.